WA
LAB icon

Wasatch Advisors’s Standard BioTools LAB Stock Holding History

Wasatch Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-221,531
Closed -$1.3M – 304
2017
Q4 		$1.3M Sell
221,531
-31,359
-12% -$172K 0.02% 244
2017
Q3 		$1.27M Sell
252,890
-65,111
-20% -$274K 0.02% 264
2017
Q2 		$1.28M Sell
318,001
-311,103
-49% -$1.47M 0.02% 289
2017
Q1 		$3.58M Sell
629,104
-1,223,689
-66% -$7.75M 0.05% 198
2016
Q4 		$13.5M Sell
1,852,793
-22,204
-1% -$139K 0.2% 94
2016
Q3 		$15M Sell
1,874,997
-26,455
-1% -$243K 0.22% 103
2016
Q2 		$17.2M Sell
1,901,452
-748,123
-28% -$7.03M 0.26% 94
2016
Q1 		$21.5M Buy
2,649,575
+232,400
+10% +$1.68M 0.33% 86
2015
Q4 		$26.1M Sell
2,417,175
-22,423
-0.9% -$220K 0.36% 87
2015
Q3 		$19.8M Sell
2,439,598
-66,820
-3% -$1.05M 0.26% 116
2015
Q2 		$60.7M Buy
2,506,418
+460,967
+23% +$14.5M 0.66% 45
2015
Q1 		$86.1M Buy
2,045,451
+51,872
+3% +$2.05M 0.89% 32
2014
Q4 		$67.2M Buy
1,993,579
+221,520
+13% +$6.27M 0.7% 44
2014
Q3 		$43.4M Buy
1,772,059
+30,588
+2% +$860K 0.45% 71
2014
Q2 		$51.2M Buy
1,741,471
+33,487
+2% +$1.07M 0.5% 63
2014
Q1 		$75.3M Sell
1,707,984
-14,188
-0.8% -$624K 0.73% 37
2013
Q4 		$66M Sell
1,722,172
-19,723
-1% -$581K 0.65% 46
2013
Q3 		$38.2M Sell
1,741,895
-31,367
-2% -$616K 0.4% 89
2013
Q2 		$31M Buy
+1,773,262
New +$31.1M 0.34% 95

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Wasatch Advisors's LAB Position: Q1 2018 in Review

Wasatch Advisors sold out of Standard BioTools (LAB) in Q1 2018, closing a stake of 221,531 shares — an estimated $1.3M sold.

Wasatch Advisors first reported a position in LAB in Q2 2013 and held it in 19 quarters. The position peaked at $86.1M in Q1 2015. 84 funds tracked by Wall St. Rank hold LAB as of Q1 2018.

  • Wasatch Advisors reported no remaining Standard BioTools position as of Q1 2018 after selling out during the quarter.
  • Wasatch Advisors sold 221,531 Standard BioTools shares in Q1 2018, an estimated $1.3M.
  • Wasatch Advisors first reported a position in Standard BioTools in Q2 2013 and held it in 19 quarters.
  • Wasatch Advisors's Standard BioTools position peaked at $86.1M in Q1 2015.
  • 84 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2018.

Based on Wasatch Advisors's 13F filing for Q1 2018, filed 2 May 2018.